Press Releases 04-03-2026 Breathe Biologics, Inc. Announces IND Amendment for IND Transfer in eCTD Format 03-22-2026 Breathe Biologics, Inc. Announces Filing of IND Amendment for RMAT Designation with FDA 02-27-2026 Breathe Biologics, Inc. names Ed Johnson as Chief Executive Officer 11-09-2022 Therapeutic Solutions International Launches Spin-Off Breathe Biologics Aimed at Curing Chronic Obstructive Pulmonary Disease (COPD)
